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Cervical cancer is still the cause of morbidity and mortality worldwide; it ranks as the fourth 
most common cancer in women worldwide. Early diagnosis has been shown to reduce 
morbidity and mortality due to cervical cancer. Although health-care providers can influence 
women’s screening behaviours, their lack of recommendations for the test becomes one 
barrier that affects the women’s participation in the screening programmes.  This study aims 
to assess the health-care providers’ perception, attitude toward and recommendation practice 
of cervical cancer screening. Sixteen in-depth interviews were conducted face to face with 
health-care providers, from both public and private sectors in Az-Zawiya city since February 
until July 2014. The interviews were recorded, transcribed, and then analysed using thematic 
analysis. The findings of this study highlight the importance of women’s motivation to attend 
cervical cancer screening programs. It also expressed a need for implementation of reminding 
system. On the other hand, this study showed the shortage amongst health care providers in 
advising and giving enough information regarding cervical cancer screening. In addition, 
Health care providers stated the necessity for educational and awareness campaigns of 
cervical cancer screening among Libyan women. Also appeared is the need to improve health 
education by the health-care providers. 









Cervical cancer is still the cause of morbidity and mortality despite the success of cervical 
cancer screening programmes and HPV immunisation programmes (Queensland Cervical 
Screening Program, 2009). It is the fourth most common cancer in women worldwide, with 
an estimated 528,000 new cases and 266,000 deaths in 2012 (Jacques Ferlay et al., 2015). In 
Libya, cervical cancer is ranked third as the most frequent cancer among women and seventh 
among women aged between fifteen and forty-four (Institut Català d'Oncologia, 2014). 
Annually 241 new cervical cancer cases are diagnosed with estimated 95 deaths registered 
every year (Bruni L et al., 2015).  
Prevention, early diagnosis and treatment have been shown to reduce mortality due to 
cervical cancer. Since 1940s, the Pap smear test has been effective in detecting cervical 
cancer (GN, 1948). The test can detect any abnormalities of the cervix at an early stage and 
medical intervention can avoid the possible progression to cervical cancer (Queensland 
Cervical Screening Program, 2009). In Libya, the Pap smear test is available in some of the 
general hospitals and a number of private clinics, although the screening uptake in most of 
Middle East and Arabic countries is still low. This is related to the low level of awareness of 
cervical cancer screening in these countries (Khadija El-Hammasi and Athari Al-Fadli, 
2009). 
While organised cervical cancer screening programmes have been introduced in most 
developed and developing countries, none exists in the Middle East or Arabic countries 
(Khadija El-Hammasi and Athari Al-Fadli, 2009). The developed countries have established 
regular screening for eligible women, and this  have reduced mortality cases from invasive 
cervical cancer (Peter Barton-Smith et al., 2003, Sankaranarayanan et al., 2001). In Iceland, 
Finland, Sweden, and Denmark, the implementation of organised, population-based cervical 
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screening programmes has significantly reduced cervical cancer mortality (International 
Agency for Research on Cancer, 1986).  
Health care providers play a key role in cervical cancer control by informing women to seek 
medical attention for abnormal vaginal bleeding and other clinical symptoms (BC Cancer 
Agency, 2013). Lack of recommendation by health-care providers has prevented women 
from taking the Pap smear test (Wong L P et al., 2009). Health-care providers can influence 
women’s screening behaviours (Wong L P et al., 2009) and increase their confidence in 
cervical cancer screening by helping them understand the importance of regular screening 
and the benefits of the Pap smear test. It is also important for the health-care providers to 
inform the women that any symptoms such as bleeding, discharge, or pain between the Pap 
smear tests may require investigation even if the previous result is normal (Queensland 
Cervical Screening Program, 2009).  
Healthcare providers play an important role in getting patients screened for cancer; they 
should discuss with women the balance between the potential benefits and harms of screening 
with Pap tests. This is to help the women make informed decision about screening which is 
consistent with their values and preferences (Canadian Task Force on Preventive Health 
Care, 2013). This qualitative study was conducted to identify the provider’s attitude toward 
and recommendation practice of cervical cancer screening among women in Az-Zawiya City, 
Libya. 
Methods 
Qualitative in-depth interviews were conducted with health-care providers from public and 
private sectors in Az-Zawiya City between February to July 2014 to assess their attitude and 
practice of cervical cancer screening. A semi-structured interview guideline was developed, 
beginning with the researcher introducing herself and informing the reasons for the interview. 
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The researcher then sought the participants’ perceptions, attitudes, and recommendation 
practices on cervical cancer screening. 
For a qualitative study, a large sample size is not as important as the depth and details of data 
obtainable by the researcher (Sandelowski, 1995). For the face-to-face interviews, sixteen 
informants were selected by purposive sampling; eight were specialists in gynaecology and 
eight were general practitioners.  
In Az-Zawiya city, there are two main hospitals with total of 616 beds, three in-patient clinics 
with capacity of 82 beds and 32 outpatient clinics (World Health Organization, 2007). 
Regrettably, the two public hospitals lack for cervical cancer screening and usually transfer 
women with warning signs or symptoms of cervical cancer to Sabratha oncology centre 
which lies 25 km away from the city centre. On the other hand, there was only one inpatient 
clinic and two outpatient clinics provide Pap smear test service and women had to pay 50 
USD to get it. 
In the first public hospital there were 6 gynaecologists and 29 general practitioners. The other 
hospital had 5 gynaecologists and 32 general practitioners .Through the heads of departments, 
one gynaecologist and another general practitioner were approached from each hospital to 
participate in the study. In the polyclinics, in-patient clinics and out-patient clinics, 
gynaecologists and general practitioners usually range from one to four. The study was 
approached two gynaecologists and two general practitioners from each of them. All 
participants from both public and private sector were very cooperative and none of targeted 
doctors declined to participate in the study  
The interviews were conducted in Arabic and were later translated to English for analysis. 
The duration of each interview was about 40 minutes. The researcher was organized the time 
and place of interview with each participant. Most of interviews were conducted in 
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participant’s workplace as they proposed and only three were at participant’s home. To get 
greater conversation and more detailed information, the interviews were carried out in closed 
offices or rooms at the chosen place.  All conversations were tape-recorded with permission 
and the field notes were taken at the same time of recording.  
Thematic analysis is the most commonly used method of analysis in a qualitative research, 
and it is used to capture the complexities of meaning within the textual data set (Gery W. 
Ryan and Bernard, 2000). Once completed, the interviews were transcribed verbatim to yield 
the textual data. These data were then checked with the field notes for consistency. Codes 
were developed to serve as labels for sections of the data. The coding procedure included two 
steps: the basic coding where data description was done, and the axial coding which included 
conceptual ordering.  
Ethics approval was obtained from University Malaya Medical Centre (UMMC) Ethics 
Committee under reference number 982.15. A written informed consent was obtained from 
all the study participants, in addition to verbal permissions to allow audio recording of the 
interview. 
Results  
The participants consisted of fourteen females and two males from the public and private 
sectors. Those healthcare providers were with seven and more years of working experience at 
the time of interview. Figure 1 shows the sampling procedure used for selecting the health-
care providers.  In general, not much difference was noted in the comments made by the 
health-care providers from the public or private sector, or from the specialists or general 
practitioners. The findings of this study explain the healthcare providers’ attitude, 
recommendation practices, and perceptions regarding cervical cancer screening. 




In general, the interviews showed a shortage among health-care providers in both sectors in 
providing enough information about cervical cancer screening for their patients. The 
compliance for cervical cancer screening among women will be low as a result of lack of 











1. Explanation by Health-care Providers on the Pap Smear Test  
None of the participants reported that they explain to healthy women about cervical cancer 
screening. They only explain about the test to women who are suspected or symptomatic of 
cervical cancer, and they may also give information about the screening test to patients aged 
thirty and above. Participants clarified that they describe the nature of Pap smear test and 
simplify that the test is only a screening test for cancerous cells in early time, and how is the 
detection of the abnormal cells effective in saving the women’s lives. As a result, giving 
information about cervical cancer screening and explanation about its procedure is only 
restricted to symptomatic and elder women. Consequently, those who are young and healthy 
may never get information from the health-care providers.  
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Figure 1 Purposive sampling Diagram of key informants 
8 
 
“I usually ask patients at risk, like those who have signs and symptoms of cervical 
cancer. As well as, those who are more than 30 years old, because this age regards as 
one of cervical cancer risk factors” (Female GP, 9 years work experience at 
polyclinic) 
2. Compliance for Cervical Cancer Screening Test 
Seven participants, five from public hospital and two from private clinics, indicated that 
healthy women may agree to undertake a cervical cancer screening test if they get sufficient 
information about it. The other three participants from public sector and one from inpatient 
clinic mentioned that women do not go for a screening test without having any warning signs 
or symptoms. The health-care providers also clarified that the attendance for regular cervical 
cancer screening depends on many factors varying from one woman to another, and the 
factors are the women’s awareness of cervical cancer screening, education level, age, health 
status, family history, and economic situation. 
“The acceptance of doing regular Pap smear depends on woman herself, her 
education level and economic status. For example; educated women tend to accept to 
do screening more than uneducated. In addition, those who have symptoms or family 
history of cervical cancer usually accept and do the test directly. Particularly, when I 
explain to them that the test will protect your life”. (Female GP, 12 years of work 
experience at inpatient clinic) 
Barriers Affecting Women’s Participation in Regular Cervical Screening 
Several barriers that may hinder women’s participation in cervical cancer screening were 
identified through this study and were classified as follows:   
1. Health-care provider-related barriers: These barriers include the obstacles that 
prevented the health-care providers from explaining or inviting women for cervical 
cancer screening, which are:  
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a. Limited time for consultation: Two specialists from private clinics and two 
general practitioners from public sector mentioned that they lack the time to 
discuss with every patient about cervical cancer screening. They attend to a large 
number of patients thus restricting their duration of consultations. 
“I am working in public hospital and usually there is large number of patients 
every day. So, it is difficult to explain for each patient as a result of limited 
time”. (Female specialist, 7 years of work experience at polyclinic)  
b. Gender of health care provider:  Two male participants indicated that the gender 
of health-care provider affects women’s acceptance to do the Pap smear test: 
Because I am male doctor, many women feel uncomfortable to talk about 
pelvic examinations. So, they always prefer to go for female doctor. And 
fortunately, in our city, female gynaecologists are much more than males. 
(Male GP, 9 years of work experience at public hospital) 
2. Health System related barriers: The most prevalent system barriers to cervical 
cancer screening  reported among the study were: 
a. Accessibility of the Screening Test: Majority of participated health-care providers 
mentioned that Pap smear test is not available in the public sector except in 
Sabratha Oncology Centre. This centre provides the service only for women who 
have signs of cervical cancer and were being referred from other hospitals or 
clinics. Women with no symptoms may not get a chance for screening in this 
oncology centre. Moreover, this centre is located far away and women need to 
travel long distance to access the service. Additionally, in the private sector, only 
some clinics provide cervical cancer screening service. The cost for a Pap smear 
test is high; it costs USD50, thus women may refuse to take the test.  
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“When I ask the patient to go for such a screening, I should refer her to the 
place in which she does the test. And because Sabratha cancer centre regards 
quit far from Az-Zawiyah city, that may cause problem for some women on 
how to go there. On the other hand, when I refer her to private clinic, first 
thing she will ask about is the PRICE of Pap smear test. And in this case, she 
may refuse to go because of high cost of the test,…especially if she doesn’t 
have any signs or symptoms of cervical cancer”. (Female GP, 18 years of 
work experience at public hospital) 
b. The cost of screening test: Participants clarified that cervical cancer screening is 
not provided in public sector and women have to pay for the test in the private 
sector. In addition, most women consider that USD50 is unreasonable when they 
are not having any warning signs of cervical cancer.    
Sometimes I ask some women for blood test which costs not more than 10 
dollars; they may not come back with the result. (Female GP, 8 years of work 
experience at polyclinic) 
3. Consumer-related barriers: The participants mentioned number of barriers that 
hinder a woman from attending the screening programme. At most they perceived that 
low level of awareness among Libyan women is the main reason and that women 
often refuse to do the test because they don’t have any signs or symptoms.  
A need of husband’s approval and support of doing cervical cancer screening test was 
also mentioned as a barrier to a screening procedure, as stated by seven participants 
from both the public and the private sector.   
From my experience, I saw some husbands who never care about their wives. 
And they may not prefer to pay for a screening test without any symptoms. 
Financial assistance by husbands is regarded as the main factor for women to 
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participate in the screening programme. (Female specialist, 13 years of work 
experience at outpatient clinic) 
For some women, shyness, neglect, lack of time, fear of knowing the test result, and 
accessibility to the test are the barriers to do the screening test as mentioned by some 
of the interview participants.  
The Health-care Providers’ Perceptions Regarding Cervical Cancer Screening 
The health-care providers expressed their worrying about women’s awareness as well as 
limited health system service of cervical cancer screening, and they highlighted some 
suggestions to improve cervical cancer screening in Libya, in terms of motivation of women 
to attend regular cervical cancer screening, implementation of reminding system, and their 
opinion to the current costs of the Pap smear test. 
1. Motivation for Women to attend Regular Cervical Cancer Screening   
According to the participants, what motivate women are time, money, and power. Hence 
they proposed the following ways to motivate women and increase their attendance for 
regular cervical cancer screening: 
a. Educational and Awareness Campaigns 
Most of the participants explained about the importance of educational and awareness 
campaigns to increase women’s awareness of cervical cancer warning signs and risk 
factors, as well as early detection of cervical cancer through regular screening. A female 
specialist from an inpatient clinic said:  
Since 4 years ago, there has been a breast cancer awareness campaign performed 
through one month in year among all secondary schools in Libya. This campaign has 
improved the women’s awareness of breast cancer. And because of these campaigns 
we received many patients intended for early diagnosis of breast cancer and 
consequently we could discover a number of cases in early stages. So, these 
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awareness campaigns will improve women’s awareness of cervical cancer and will 
increase their attendance for Pap smear test. (Female specialist, 8 years of work 
experience at inpatient clinic) 
b. Media, Posters, and Leaflets 
The health-care providers also mentioned about the significance of media in increasing 
woman’s motivation to attend regular screening. Posters and leaflets can explain about 
cervical cancer warning signs and risk factors, and the importance of detecting the disease 
early to save a woman’s life, and this form of media can be distributed in schools, 
universities, clinics and hospitals. 
 Information dissemination through posters and leaflets in public places may draw the 
attention of women. These posters should highlight cervical cancer risk factors, 
warning signs and the importance of early screening. (Female GP, 12 years of work 
experience at inpatient clinic)  
c. Offering a Free Pap Smear Test 
Five participants from both public and private sectors stated that offering the Pap test 
free-of-charge may increase women’s attendance for screening. Woman usually will not 
pay for such a costly service without having any symptoms thus a free screening in the 
public sector will motivate them to do the test regularly.  
Pap smear is not available in public sector. Usually, when I ask women to do the Pap 
test, they need to go to the private sector and in this case, they may not accept 
because of financial issues. But if the service is provided in public sector as free, 
women’s attendance will be increased. (Male GP, 9 years of work experience at 
public hospital) 
2. Reminding Women to do Regular Screening 
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Most participants indicated that reminding the women to do a regular Pap smear test after 
three years is not easy. Hence implementing the reminding system requires a good 
planning, time, and efforts, and this was regarded as one of the main roles of the Ministry 
of Health. 
a. Implementation of Proper Reminding System 
Seven health-care providers mentioned about the importance of implementing of a call-
recall system such as the one available in developed countries, while the other five 
participants from both sectors highlighted the difficulty of implementing such a 
programme in this time because of limited current resources. Some indicated that 
awareness campaigns with doctors’ encouragement will improve the women’s attendance 
for screening programmes. A female specialist at an outpatient clinic proposed 
compulsory attendance for a screening programme:  
We can do,,, that the attendance for Pap smear screening is compulsory. And small 
booklets can be given as a reminder, and those who don’t come for their next 
screening date have to pay fine. In this case we may get 100% Pap smear screening. 
(Female GP, 12 years of work experience at outpatient clinic) 
b. Attendance without Reminding 
The health-care providers were asked women’s attendance without encouragement and 
reminding. Fourteen participants answered, “No”, or that the women would never attend.  
The other two participants highlighted that women’s awareness of cervical cancer 
screening plays an important role in their attendance without reminding. 
 “Women’s attendance without reminding depends on women’s awareness of cervical 
cancer screening. Most of Libyan women have no idea about Pap smear test, but if 
they get adequate information and the test be obtainable, then their attendance will be 
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improved and they may come without reminding”.  (Male specialist, 20 years of work 
experience at public hospital) 
3. Health-Care Providers’ Opinion of the Cost of Pap Smear Test  
Half of the participants indicated that fifty dollars is not expensive to be paid every three 
years. They explained that this amount will be paid to detect any abnormal cells in the cervix, 
and then woman’s life can be saved rather discovering cervical cancer at later stages.  
Fifty dollars is not expensive at all and woman will pay it once every three years…. 
And by this amount she may avoid payment of thousands of dollars to cure from 
cervical cancer lesions in future. (Female specialist, 16 years of work experience at 
public hospital) 
Other participants perceived that the amount of fifty dollars is expensive to pay for a 
screening test. As a result of the low level of awareness of screening test among women, they 
may not prefer to pay without any warning signs appeared.  
In addition, some of interviewees expressed that the cost of a Pap smear test depends on the 
woman herself. It depends on her level of awareness and education, socio-economic status 
and her family history. Educated women aware of the screening test, women with high socio- 
economic status, and those who have family background of cervical cancer may accept to pay 
for cervical cancer screening test. 
Discussion  
Health-care provider plays a crucial role in educating women about the benefits of cervical 
cancer screening and the importance of regular a Pap smear test (BC Cancer Agency, 2013, 
L. P.Wong et al., 2008). Encouragement and motivation from doctors appeared to be an 
important factor in assuring that the women would attend for a Pap smear test (Taylor VM et 
al., 2002, Tung T. Nguyen et al., 2002, Anisah Baharom and Ismail., 2008). Apparently the 
health-care providers in Az-Zawiya city do not explain about a Pap smear test for their 
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asymptomatic patients. An earlier qualitative study performed among Malaysian women 
confirmed that they have never been informed of the existence and importance of a Pap 
smear test by health-care professionals (Wong L P et al., 2009). 
The study indicated a shortage of health-care providers in giving information about cervical 
cancer screening for their patients. Providing information and recommendation of health 
professionals are only restricted to elderly women and those who have warning signs or 
symptoms of cervical cancer. However, a study performed in 2009 among Vietnamese 
immigrants in Seattle, Washington to demonstrate the importance of health care factors 
highlighted the significance of intervention programmes to improve patient-provider 
communication, particularly by encouraging health-care providers to recommend Pap smear 
testing (Taylor et al., 2009). 
The commonest weakness of cervical cancer screening mentioned in the interviews was the 
accessibility of Pap smear test. According to the Ministry of Health in Az-Zawiya city, Pap 
smear test is available in one public hospital which is Sabratha Oncology Hospital. This 
hospital provides the service as free of fees, but the test is only applicable for patients who 
have been transferred from other hospitals and clinics. Therefore, women who plan to do 
cervical cancer screening have to go to the private sector and pay for the test. Consequently, 
accessing the service from a particular location may be difficult for women as demonstrated 
by previous studies (Queensland Cervical Screening Program, 2009, Marion Maar et al., 
2013).  
Some of health-care providers stated that the frequent refusal of cervical cancer screening 
among their asymptomatic patients have made them unwilling to spend time to explain about 
the Pap smear test. A qualitative study performed in 2010 found that all participants admitted 
poor women’s acceptability to cervical cancer screening programme (Abdullah and Su, 
2010). Hence unacceptability and frequent refusal of women to participate in cervical cancer 
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screening programme have discouraged the health-care providers in giving advice and 
support to asymptomatic women. 
The health-care providers highlighted a few barriers that prevent women from performing a 
regular Pap smear test. Low level of awareness about screening test was the main factor; 
women lack adequate knowledge about the importance of a Pap smear test. A study 
performed among Malaysian women in 2009 found that women were poorly aware of the 
indications and benefits of cervical cancer screening and they were not aware that a Pap 
smear test is for the early detection of cervical cancer (Wong L P et al., 2009).  
Participated health-care providers were underlined some other barriers of cervical cancer 
screening, and that has emphasized the findings of previous studies. For example, 
Participants mentioned about the financial factor which is significantly affect women’s 
participation in cervical cancer screening. This was confirmed previously through the case 
studies on decision for cervical cancer screening which underlined that woman will only have 
her Pap smear done if she has extra money (Anisah Baharom and Ismail., 2008). Moreover, 
the gender of health care provider may affect women’s acceptance of doing a Pap smear test 
(Queensland Cervical Screening Program, 2009, Nseem Mohamed Bakheit and Haroon, 
2004). A study performed in Emirates concluded that in most traditional Islamic societies, 
female genital examination by a male is culturally unacceptable except in extraordinary 
circumstances in secondary care (Padmanabhan Badrinath et al., 2010, Nseem Mohamed 
Bakheit and Haroon, 2004). The health-care providers in this study indicated the importance 
of husband’s approval and support to do a Pap smear test. A case study performed in 
Malaysia highlighted the role of husband in encouraging women to practice preventive health 
care (Anisah Baharom and Ismail., 2008).   
This study has stressed the importance of educational and awareness campaigns to improve 
women’s attendance for cervical cancer screening programmes. Improving education and 
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information dissemination about a Pap smear test through awareness campaigns will increase 
their awareness of cervical cancer screening (Jugal Kishore et al., 2009, Forough 
Javanmanesh et al., 2008). 
In developed countries, the implementation of call-recall organized cervical cancer screening 
programmes resulted in reduced morbidity and mortality of cervical cancer (Abdullah and Su, 
2010, Peter Barton-Smith et al., 2003). Most participants in this study mentioned the 
difficulty of reminding women every three years to practice a regular Pap smear test, and 
these interviewees stressed the importance of implementing a call-recall system to ensure 
success in increasing Pap smear test coverage.  
In conclusion, the finding of this study indicated that there is a need to improve patient- 
provider relationship. In addition to, enhancement of health system services to ensure 
comprehensive cervical cancer screening coverage. Lack of physician’s recommendation was 
found to be one of the reasons of low Pap smear test coverage (L. P.Wong et al., 2008). 
Suggestion should be made to the authorities to have to improve health education by health-
care providers. In addition, more information on cervical cancer and its screening should be 
disseminated especially in electronic media as well as in educational and awareness 
campaigns. There is also a promising possibility to increase the cervical cancer screening rate 
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